Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Signal ; 19(4): 748-60, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17113265

ABSTRACT

Sphingosine 1-phosphate (S1P) levels in cells and, consequently, its bioactivity as a signalling molecule are controlled by the action of enzymes responsible for its synthesis and degradation. In the present report, we examined alterations in expression patterns of enzymes involved in S1P-metabolism (sphingosine kinases including their splice variants, sphingosine 1-phosphate phosphatases, and sphingosine 1-phosphate lyase) under certain inflammatory conditions. We found that sphingosine kinase type 1 (SPHK1) mRNA could be triggered in a cell type-specific manner; individual SPHK1 splice variants were induced with similar kinetics. Remarkably, expression and activity of S1P phosphatase 2 (SPP2) was found to be highly upregulated by inflammatory stimuli in a variety of cells (e.g., neutrophils, endothelial cells). Bandshift analysis using oligonucleotides spanning predicted NFkappaB sites within the SPP2 promoter and silencing of NFkappaB/RelA via RelA-directed siRNA demonstrated that SPP2 is an NFkappaB-dependent gene. Silencing of SPP2 expression in endothelial cells, in turn, led to a marked reduction of TNF-alpha-induced IL-1beta mRNA and protein and to a partial reduction of induced IL-8, suggesting a pro-inflammatory role of SPP2. Notably, up-regulation of SPP2 was detected in samples of lesional skin of patients with psoriasis, an inflammatory skin disease. This study provides detailed insights into the regulation of SPP2 gene expression and suggests that SPP2 might be a novel player in pro-inflammatory signalling.


Subject(s)
Inflammation/enzymology , Membrane Proteins/biosynthesis , Phosphoric Monoester Hydrolases/biosynthesis , Binding Sites/drug effects , Cells, Cultured , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelial Cells/enzymology , Enzyme Induction/drug effects , Gene Expression Profiling , Gene Silencing/drug effects , Humans , Interleukin-1beta/metabolism , Lipopolysaccharides/pharmacology , Lysophospholipids/metabolism , Membrane Proteins/genetics , NF-kappa B/metabolism , Neutrophils/drug effects , Neutrophils/enzymology , Phosphoric Monoester Hydrolases/genetics , Phosphotransferases (Alcohol Group Acceptor)/genetics , Promoter Regions, Genetic/drug effects , Psoriasis/enzymology , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/metabolism , Skin/enzymology , Skin/pathology , Sphingosine/analogs & derivatives , Sphingosine/metabolism , Transcription, Genetic/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Up-Regulation/drug effects
2.
Cell Cycle ; 5(15): 1662-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16861932

ABSTRACT

HDAC inhibitors are promising antitumor drugs with several HDAC inhibitors already in clinical trials. LAQ824, a potent pan-HDAC inhibitor, has been shown to induce cell cycle arrest and cell death. However, the mechanism of its antitumor effects and specially its tumor selectivity are still poorly understood. The focus of this study is to elucidate LAQ824 mediated anti-proliferative effects in lung carcinoma cells and the mechanism underlying the different sensitivity of LAQ824 to cancer and normal cells. In this study, LAQ824 mediated apoptosis was found to occur mainly via activation of the mitochondrial death pathway by inducing Apaf1 and caspase 9 and promoting mitochondrial release of key proapoptotic factors in lung cancer cells, but not in normal fibroblast cells. Using chromatin immunoprecipitation assay, we found that RNA Pol II binding and histone H3 acetylation levels at Apaf1 promoter were increased following LAQ824 treatment, explaining LAQ824 induced expression of Apaf1 in lung cancer cells. Furthermore, we showed that LAQ824 only triggered the release of mitochondrial proapoptotic factors such as cytochrome C (Cyto C) and apoptosis inducing factor (AIF) in lung cancer cells but not in normal blast cells. In addition, LAQ824 was found to induce Bax translocation in lung cancer cell, which may play important role in the induction of the release of mitochondrial proapoptotic factors. These data provide insight into the mechanism underlying the selective induction of apoptosis by LAQ824 in cancer cells.


Subject(s)
Apoptosis/drug effects , Hydroxamic Acids/pharmacology , Lung Neoplasms/pathology , Mitochondria/drug effects , Acetylation/drug effects , Caspases/metabolism , Dose-Response Relationship, Drug , Fibroblasts/cytology , Fibroblasts/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Histones/metabolism , Humans , Lung Neoplasms/genetics , Mitochondria/metabolism , Protein Transport/drug effects , Time Factors , Tumor Cells, Cultured , bcl-2-Associated X Protein/metabolism
3.
Curr Opin Chem Biol ; 10(4): 303-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16822705

ABSTRACT

Considerable progress has been made in exploiting the enormous amount of genomic and genetic information for the identification of potential targets for drug discovery and development. New tools that incorporate pathway information have been developed for gene expression data mining to reflect differences in pathways in normal and disease states. In addition, forward and reverse genetics used in a high-throughput mode with full-length cDNA and RNAi libraries enable the direct identification of components of signaling pathways. The discovery of the regulatory function of microRNAs highlights the importance of continuing the investigation of the genome with sophisticated tools. Furthermore, epigenetic information including DNA methylation and histone modifications that mediate important biological processes add to the possibilities to identify novel drug targets and patient populations that will benefit from new therapies.


Subject(s)
Drug Evaluation, Preclinical/methods , Genomics/methods , Animals , Computational Biology , Epigenesis, Genetic , Gene Expression , Genetic Predisposition to Disease/genetics , Humans , MicroRNAs/analysis
4.
BMC Bioinformatics ; 6: 242, 2005 Oct 03.
Article in English | MEDLINE | ID: mdl-16202129

ABSTRACT

BACKGROUND: The sequencing of the human genome has enabled us to access a comprehensive list of genes (both experimental and predicted) for further analysis. While a majority of the approximately 30,000 known and predicted human coding genes are characterized and have been assigned at least one function, there remains a fair number of genes (about 12,000) for which no annotation has been made. The recent sequencing of other genomes has provided us with a huge amount of auxiliary sequence data which could help in the characterization of the human genes. Clustering these sequences into families is one of the first steps to perform comparative studies across several genomes. RESULTS: Here we report a novel clustering algorithm (CLUGEN) that has been used to cluster sequences of experimentally verified and predicted proteins from all sequenced genomes using a novel distance metric which is a neural network score between a pair of protein sequences. This distance metric is based on the pairwise sequence similarity score and the similarity between their domain structures. The distance metric is the probability that a pair of protein sequences are of the same Interpro family/domain, which facilitates the modelling of transitive homology closure to detect remote homologues. The hierarchical average clustering method is applied with the new distance metric. CONCLUSION: Benchmarking studies of our algorithm versus those reported in the literature shows that our algorithm provides clustering results with lower false positive and false negative rates. The clustering algorithm is applied to cluster several eukaryotic genomes and several dozens of prokaryotic genomes.


Subject(s)
Algorithms , Neural Networks, Computer , Sequence Alignment , Sequence Analysis, Protein/methods , Benchmarking , Cluster Analysis , ROC Curve , Sequence Homology, Amino Acid , Software Validation
5.
Oncogene ; 22(40): 6204-13, 2003 Sep 18.
Article in English | MEDLINE | ID: mdl-13679859

ABSTRACT

The dynamic balance between histone acetylation and deacetylation plays a significant role in the regulation of gene transcription. Much of our current understanding of this transcriptional control comes from the use of HDAC inhibitors such as trapoxin A (TPX), which leads to hyperacetylated histone, alters local chromatin architecture and transcription and results in tumor cell death. In this study, we treated tumor cells with TPX and HDAC1 antisense oligonucleotides, and analysed the transcriptional consequences of HDAC inhibition. Among other genes, the small GTPase RhoB was found to be significantly upregulated by TPX and repressed by HDAC1. The induction of RhoB by HDAC inhibition was mediated by an inverted CCAAT box in the RhoB promoter. Interestingly, measurement of RhoB transcription in approximately 130 tumor-derived cell lines revealed low expression in almost all of these samples, in contrast to RhoA and RhoC. Accumulating evidence indicates that the small GTPase Rho proteins are involved in a variety of important processes in cancer, including cell transformation, survival, invasion, metastasis and angiogenesis. This study for the first time demonstrates a link between HDAC inhibition and RhoB expression and provides an important insight into the mechanisms of HDAC-mediated transcriptional control and the potential therapeutic benefit of HDAC inhibition.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Histone Deacetylase Inhibitors , Lung Neoplasms/genetics , Monomeric GTP-Binding Proteins/metabolism , Peptides , rhoB GTP-Binding Protein/metabolism , Acetylation/drug effects , Anti-Bacterial Agents/pharmacology , Base Sequence , CCAAT-Binding Factor/metabolism , Carcinoma, Non-Small-Cell Lung/enzymology , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Transformed , Enzyme Inhibitors/pharmacology , Humans , Lung Neoplasms/enzymology , Lung Neoplasms/pathology , Molecular Sequence Data , Monomeric GTP-Binding Proteins/genetics , Promoter Regions, Genetic , Repressor Proteins/antagonists & inhibitors , Tumor Cells, Cultured , Up-Regulation , rhoB GTP-Binding Protein/genetics
6.
J Biol Chem ; 277(8): 6656-66, 2002 Feb 22.
Article in English | MEDLINE | ID: mdl-11739383

ABSTRACT

A novel histone deacetylase, HDAC10, was isolated from a mixed tissue human cDNA library. HDAC10 was classified as a class II subfamily member based upon similarity to HDAC6. The genomic structure of HDAC10 was found to consist of 20 exons. HDAC10 has two sequence variants, HDAC10v1 and HDAC10v2, and two transcripts were detectable by Northern blot analysis. HDAC10v1 and HDAC10v2 were found to be identical through exon 17 but diverged after this exon. HDAC10v2 has an 82-bp alternate exon that generates a frameshift and shortens the sequence by 11 amino acids. In this study, the characterization of HDAC10v1 was performed. HDAC10v1 has an N-terminal catalytic domain, two putative C-terminal retinoblastoma protein binding domains, and a nuclear hormone receptor binding motif. The HDAC10v1 enzyme was found to be catalytically active based upon its ability to deacetylate a (3)H-acetylated histone H4 N-terminal peptide. Immunofluorescence detection of transfected HDAC10v1-FLAG indicated that the enzyme is a nuclear protein. Furthermore, coimmunoprecipitation experiments indicated that HDAC10v1 associated with HDAC2 and SMRT (silencing mediator for retinoid and thyroid hormone receptors). In addition, based upon the public data base, a single nucleotide polymorphism was found in the C terminus of HDAC10 which changes a Gly residue to Cys, suggesting that HDAC10 molecules containing these single nucleotide polymorphisms may be folded improperly. HDAC10 extends the HDAC superfamily and adds to a growing number of HDACs that have been found to have splice variants, suggesting that RNA processing may play a role in mediating the activity of HDACs.


Subject(s)
Genetic Variation , Histone Deacetylases/genetics , Amino Acid Sequence , Base Sequence , Catalytic Domain , Cell Line , DNA, Complementary/genetics , Female , Gene Library , Histone Deacetylases/isolation & purification , Histone Deacetylases/metabolism , Humans , Male , Molecular Sequence Data , Organ Specificity , Polymerase Chain Reaction , Sequence Alignment , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...